Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $0 | $0 | $9,700 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | $29,300 | $6,500 | $28,000 |
| Other Non-Cash | – | $8,200 | -$29,900 | $20,700 |
| Operating Cash Flow | – | $37,500 | -$23,400 | $58,400 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | -$4,400 | -$6,800 | -$4,600 |
| Investing Cash Flow | – | -$4,400 | -$6,800 | -$4,600 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $50,100 | -$11,300 | -$72,300 |
| Financing Cash Flow | – | $50,100 | -$11,300 | -$72,300 |
| Forex Effect | – | -$100 | -$100 | $0 |
| Net Chg. in Cash | – | $83,100 | -$41,600 | -$18,500 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $24,700 | $66,300 | $84,800 |
| End Cash | – | $107,800 | $24,700 | $66,300 |
| Free Cash Flow | – | $8,800 | -$23,400 | $58,400 |